Northwest Biotherapeutics Inc Revenue per Employee (NWBO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Northwest Biotherapeutics Inc  (NONE: NWBO)
 

Northwest Biotherapeutics Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 516.03% in the second quarter 2026, year on year to cumulative value of $2 million, Northwest Biotherapeutics Inc's revenue per employee grew on a trailing twelve months basis to $ 20,695. The productivity of Northwest Biotherapeutics Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 532 other companies have achieved higher revenue per employee. While Northwest Biotherapeutics Inc's total ranking has deteriorated compared to the previous quarter from 3202 to 3534. Northwest Biotherapeutics Inc has 105 employees.


What is Sales per Employee Ratio?







NWBO Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 516.03 % 31.73 % 190.91 % -43.98 % -74.31 %
Sales per Employee (TTM) $ 20,695 14,257 13,124 8,924 10,419
NWBO's Total Ranking # 3534 # 3202 # 3253 # 2480 # 2805
Seq. Revenue Change 63.36 % -26.49 % 236 % 52.67 % -65.07 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 190
Healthcare Sector # 533
Overall Market # 3534

Revenue per Employee Statistics
High Average Low
$ 25,152 $ 12,825 $ 3,200
(Mar 31 2020)   (Dec 31 2017)



Financial Statements
Northwest Biotherapeutics Inc's Revenue MRQ $ 1 Millions Visit NWBO's Income Statement
Northwest Biotherapeutics Inc's Revenues TTM $ 2 Millions Visit NWBO's aggregate revenue growth
What are NWBO's Sales? Visit NWBO's Sales by Segment




Other Ratios
Northwest Biotherapeutics Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NWBO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NWBO's Competitors
Revenue per Employee for NWBO's Suppliers
Revenue per Employee for NWBO's Customers

You may also want to know
NWBO's Sales Growth Rates NWBO's Pe Price to earnings ratio NWBO's Receivables Turnover Ratio NWBO's Stock Quote
NWBO's Net Income Growth Rates NWBO's Ps Price to Sales ratio NWBO's Sales per Employee NWBO's Asset Turnover Ratio
NWBO's Net Margin NWBO's Pb Price to Book ratio NWBO's Financial Strength Ratios NWBO's Dividend Payout Ratio
Date modified: 2026-08-18T17:26:23+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Alumis inc   33,026.79 $ 7.398  Million 224 
Volitionrx Limited  32,773.92 $ 2.458  Million 75 
Longeveron Inc   31,236.84 $ 1.187  Million 38 
Dbv Technologies S a   29,517.65 $ 5.018  Million 170 
Addus Homecare Corp  29,128.29 $ 1,475.610  Million 50,659 
Insight Molecular Diagnostics Inc   28,793.10 $ 1.670  Million 58 
Scientific Industries Inc   28,357.43 $ 5.728  Million 202 
Nexalin Technology Inc   27,144.38 $ 0.217  Million
Bioxcel Therapeutics Inc   25,586.21 $ 0.742  Million 29 
Bioadaptives Inc   25,561.00 $ 0.026  Million
Ataibeckley Inc   22,143.56 $ 4.473  Million 202 
Envoy Medical Inc   20,700.00 $ 0.207  Million 10 
Northwest Biotherapeutics Inc  20,695.24 $ 2.173  Million 105 
China Pharma Holdings Inc  17,710.83 $ 3.914  Million 221 
Cardiff Oncology Inc   16,387.10 $ 0.508  Million 31 
Mangoceuticals Inc   14,328.50 $ 0.315  Million 22 
Absci Corp  11,150.00 $ 1.561  Million 140 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.